Hemozoin: malaria's "built-in" adjuvant and TLR9 agonist
- PMID: 20114022
- DOI: 10.1016/j.chom.2010.01.002
Hemozoin: malaria's "built-in" adjuvant and TLR9 agonist
Abstract
The "built-in" adjuvant in a whole-microbe vaccine potentially triggers protective immunity. Coban et al. now demonstrate that crude blood stage extract of the malaria parasite Plasmodium falciparum drives parasite-specific immune responses via Hemozoin, a byproduct of heme detoxification, functioning as a TLR9 agonist and, therefore, as a "built-in" adjuvant.
2010 Elsevier Inc. All rights reserved.
Comment on
-
Immunogenicity of whole-parasite vaccines against Plasmodium falciparum involves malarial hemozoin and host TLR9.Cell Host Microbe. 2010 Jan 21;7(1):50-61. doi: 10.1016/j.chom.2009.12.003. Cell Host Microbe. 2010. PMID: 20114028